Jaguar expects first results in Q2 2025 of proof-of-concept investigator-initiated trials of crofelemer for the rare diseases short bowel ...
SAN FRANCISCO, CA / ACCESS Newswire / February 18, 2025 / Jaguar Health, Inc. ( NASDAQ:JAGX) ("Jaguar" or the "Company") and Jaguar family company Napo Pharmaceuticals ("Napo") today announced ...
Will that prove to be a disaster? It's right there alongside brands like Levi's or Nike – Jaguar flirts with Lady Death in more ways than we or they can imagine. In their quest for social media ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results